Lineus Medical

Lineus Medical is now officially registered in the United Kingdom, enabling the company to begin distributing SafeBreak® Vascular within the UK healthcare market.

Lineus Medical, the leader in vascular access innovation, has been awarded a U.S. patent for SafeBreak® Vascular Generation 2, the next evolution of the company's flagship breakaway device.

Lineus Medical has obtained CE Mark certification for its flagship product, SafeBreak® Vascular, the only breakaway device for IV lines clinically proven to reduce multiple IV complications.1 With this certification, SafeBreak Vascular is now cleared...

Lineus Medical is pleased to announce a new distribution agreement with Venture Medical, a 100% New Zealand–owned medical supplier based in Auckland.

Lineus Medical has been granted five additional international patents for its flagship product, SafeBreak® Vascular, in Korea, Brazil, Australia, India, and China.

Lineus Medical is pleased to announce the appointment of Matt Stuckert to its Board of Directors. Stuckert was previously a member of the Lineus Technical Advisory Board.

Lineus Medical announces the completion of a $4.579 million Series C funding round. The Series C round allowed Lineus Medical to expand its sales and clinical education team, secure international regulatory clearances, and obtain additional U.S.

Lineus Medical announces a significant reduction in price of nearly 15% for its flagship product, SafeBreak Vascular, in the United States.

Vance Clement, CEO of Lineus Medical, has been selected to join the Association of Vascular Access (AVA) Board of Directors as a Director at Large for a two-year term.

Lineus Medical has been awarded the 2023-2024 University of Arkansas College of Engineering Small Employer of the Year.